Saniona ABCHIX:SANIOS 66 9-Day RSI is 18.64 as of Jul. 08, 2026. GuruFocus rates CHIX:SANIOS with a GF Score™ of 66/100 and a GF Value™ of kr26.73 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,418 Biotechnology companies, Saniona AB ranks better than 56.63% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-08), Saniona AB's 9-Day RSI is 18.64.
The industry rank for Saniona AB's 9-Day RSI or its related term are showing as below:
CHIX:SANIOs's 9-Day RSI is ranked better than 56.63% of 1418
companies
in the Biotechnology industry
Industry Median: 51.815
vs CHIX:SANIOs: 18.64
Saniona AB (CHIX:SANIOs) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Saniona AB 9-Day RSI Related Terms
CHIX:SANIOS vs VRTX, REGN, ALNY: 9-Day RSI Comparison
For the Biotechnology subindustry, Saniona AB's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saniona AB 9-Day RSI vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Saniona AB's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Saniona AB's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saniona AB (CHIX:SANIOS) has a 9-Day RSI of 18.64 as of Jul. 08, 2026. According to the industry distribution chart, Saniona AB ranks #615 out of 1418 companies in the Biotechnology industry, placing it in the top 43.4%.
Is Saniona AB's 9-Day RSI too high?
Saniona AB's current 9-Day RSI is 18.64. The Biotechnology industry median 9-Day RSI is 51.82. Saniona AB's value of 18.64 is 64% below this industry median. Based on the distribution chart, Saniona AB ranks #615 out of 1418 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Saniona AB has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Saniona AB's 9-Day RSI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Saniona AB ranks #615 out of 1418 companies for 9-Day RSI. This puts Saniona AB in the upper half of its industry. The industry median 9-Day RSI is 51.82. Saniona AB's value of 18.64 is 64% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Biotechnology company?
The median 9-Day RSI among Biotechnology companies is 51.82, based on 1,418 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saniona AB's current 9-Day RSI of 18.64 is 64% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median 9-Day RSI is 51.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saniona AB's current 9-Day RSI is 18.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saniona AB stock overvalued right now?
Based on GuruFocus' analysis, Saniona AB (CHIX:SANIOS) is currently considered Significantly Undervalued. The stock's GF Value™ is kr26.73, compared to a current price of kr12.75 — trading 52.3% below its estimated fair value. The current 9-Day RSI is 18.64 and 64% below the Biotechnology industry median of 51.82. Saniona AB's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Saniona AB (CHIX:SANIOS), the current 9-Day RSI is 18.64 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Saniona AB (CHIX:SANIOS) Overvalued in 2026?
Based on GuruFocus' analysis, Saniona AB stock appears to be undervalued.
The current stock price of kr12.75 is trading 52.3% below its estimated GF Value™ of kr26.73.
GuruFocus considers Saniona AB to be Significantly Undervalued.
Key valuation signals for CHIX:SANIOS:
9-Day RSI: 18.64
GF Value™: kr26.73 vs. price of kr12.75 (52.3% below fair value)
Industry Position: 64% below the Biotechnology median (#615 of 1418)
No single metric tells the full story. See the CHIX:SANIOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
66GF Score
Get the complete analysis for CHIX:SANIOS
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SANIOS has been successfully added to your 